WO2001012806A3 - 'odorant-binding' proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications - Google Patents

'odorant-binding' proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications Download PDF

Info

Publication number
WO2001012806A3
WO2001012806A3 PCT/FR2000/002319 FR0002319W WO0112806A3 WO 2001012806 A3 WO2001012806 A3 WO 2001012806A3 FR 0002319 W FR0002319 W FR 0002319W WO 0112806 A3 WO0112806 A3 WO 0112806A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
odorant
polynucleotides coding
hydrophobic ligands
human proteins
Prior art date
Application number
PCT/FR2000/002319
Other languages
English (en)
Other versions
WO2001012806A2 (fr
Inventor
Gilles Pitiot
Eric Lacazette
Francoise Gachon
Original Assignee
Univ Clermont Auvergne
Gilles Pitiot
Eric Lacazette
Francoise Gachon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Clermont Auvergne, Gilles Pitiot, Eric Lacazette, Francoise Gachon filed Critical Univ Clermont Auvergne
Priority to AU70130/00A priority Critical patent/AU7013000A/en
Priority to EP00958685A priority patent/EP1206544A2/fr
Priority to CA002381712A priority patent/CA2381712A1/fr
Publication of WO2001012806A2 publication Critical patent/WO2001012806A2/fr
Publication of WO2001012806A3 publication Critical patent/WO2001012806A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Child & Adolescent Psychology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne de nouveaux polypeptides fixant des ligands hydrophobes et notamment des odeurs, dénommés OBPII (Odorant Binding Protein), les polynucléotides codant pour lesdits polypeptides et des anticorps spécifiques dirigés contre lesdits polypeptides. L'invention concerne également les applications de ces molécules notamment pour l'hygiène corporelle, les applications agro-alimentaires, nutritionnelles et thérapeutiques.
PCT/FR2000/002319 1999-08-12 2000-08-11 'odorant-binding' proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications WO2001012806A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU70130/00A AU7013000A (en) 1999-08-12 2000-08-11 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof
EP00958685A EP1206544A2 (fr) 1999-08-12 2000-08-11 "odorant-binding" proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications
CA002381712A CA2381712A1 (fr) 1999-08-12 2000-08-11 "odorant-binding" proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR99/10439 1999-08-12
FR9910439A FR2797447B1 (fr) 1999-08-12 1999-08-12 "odorant-binding" proteines humaines fixant des ligands hydrophobes:polypeptides et polynucleotides codant lesdits polypeptides et leurs applications

Publications (2)

Publication Number Publication Date
WO2001012806A2 WO2001012806A2 (fr) 2001-02-22
WO2001012806A3 true WO2001012806A3 (fr) 2001-08-30

Family

ID=9549103

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2000/002319 WO2001012806A2 (fr) 1999-08-12 2000-08-11 'odorant-binding' proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications

Country Status (5)

Country Link
EP (1) EP1206544A2 (fr)
AU (1) AU7013000A (fr)
CA (1) CA2381712A1 (fr)
FR (1) FR2797447B1 (fr)
WO (1) WO2001012806A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001289036A1 (en) * 2000-09-13 2002-03-26 Zymogenetics Inc. Use of human phermone polypeptides
US10227594B2 (en) 2015-03-20 2019-03-12 Conopco, Inc. Antiperspirant composition
ITUB20152569A1 (it) * 2015-07-28 2017-01-28 Univ Degli Studi Di Parma Agenti antibatterici e antimicotici ed usi derivati
WO2021152856A1 (fr) * 2020-01-31 2021-08-05 株式会社 資生堂 Procédé de criblage d'une substance toxique pour la peau à l'aide d'obp
TW202216111A (zh) 2020-07-03 2022-05-01 米尼奧大學 香氛釋放機制、方法及其用途
CN117255697A (zh) * 2021-02-23 2023-12-19 特种宠物食品公司 新型犬气味结合蛋白

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335654A2 (fr) * 1988-03-30 1989-10-04 The Johns Hopkins University Protéine liant des odeurs à partir du rat
WO1998054206A1 (fr) * 1997-05-30 1998-12-03 Human Genome Sciences, Inc. 32 proteines secretees par l'homme
WO1998059049A1 (fr) * 1997-06-20 1998-12-30 Abbott Laboratories Reactifs et procedes destines a detecter des pathologies mammaires
WO1999007740A2 (fr) * 1997-08-06 1999-02-18 Zymogenetics, Inc. Homologues de lipocaline

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335654A2 (fr) * 1988-03-30 1989-10-04 The Johns Hopkins University Protéine liant des odeurs à partir du rat
WO1998054206A1 (fr) * 1997-05-30 1998-12-03 Human Genome Sciences, Inc. 32 proteines secretees par l'homme
WO1998059049A1 (fr) * 1997-06-20 1998-12-30 Abbott Laboratories Reactifs et procedes destines a detecter des pathologies mammaires
WO1999007740A2 (fr) * 1997-08-06 1999-02-18 Zymogenetics, Inc. Homologues de lipocaline

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_EST EMBL; 30 November 1998 (1998-11-30), "qh24d02.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:1845603 3'", XP002136047 *
DATABASE EM_EST EMBL; 5 November 1998 (1998-11-05), "qh90f12.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:1854287 3'", XP002136048 *
FLOWER D: "Multiple molecular recognition properties of the lipocalin protein family", JOURNAL OF MOLECULAR RECOGNITION, vol. 8, 1995, pages 185 - 195, XP002095125, ISSN: 0952-3499 *
FLOWER D: "The lipocalin protein family: structure and function", BIOCHEMICAL JOURNAL, vol. 318, 1996, pages 1 - 14, XP002095126, ISSN: 0264-6021 *
LACAZETTE E. ET AL.: "A novel human odorant-binding protein gene family resulting from genomic duplicons at 9q34: differential expression in the oral and genital spheres.", HUM MOL GENET 2000 JAN 22;9(2):289-301, XP002135298 *
LOBEL D. ET AL.: "Subtypes of odorant-binding proteins--heterologous expression and ligand binding.", EUR J BIOCHEM 1998 JUN 1;254(2):318-24, XP000891882 *
MAKELA-BENGS PAIVI ET AL: "Assignment of the disease locus for lethal congenital contracture syndrome to a restricted region of chromosome 9q34, by genome scan using five affected individuals.", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 63, no. 2, August 1998 (1998-08-01), pages 506 - 516, XP002159515, ISSN: 0002-9297 *

Also Published As

Publication number Publication date
FR2797447B1 (fr) 2004-04-02
WO2001012806A2 (fr) 2001-02-22
EP1206544A2 (fr) 2002-05-22
FR2797447A1 (fr) 2001-02-16
AU7013000A (en) 2001-03-13
CA2381712A1 (fr) 2001-02-22

Similar Documents

Publication Publication Date Title
WO1999020756A3 (fr) Homologues toll humains
WO2000078344A8 (fr) Peptides proteiniques du prion et utilisations associees
WO2000020449A3 (fr) PROTEINES MODIFIEES DE LA SUPERFAMILLE DU TGF-$g(B)
EP1067182A8 (fr) Proteine secretoire ou proteine de membrane
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
IL161016A (en) Polypeptides capable of ang-2 binding
EP2261246A3 (fr) Polypeptides de liaison pour la protéine stimulatrice des lymphocytes B (BLyS)
WO2001068708A3 (fr) ANTICORPS HUMAINS SPECIFIQUES DE FAP-$g(a)
AU3186397A (en) Prion protein binding proteins and uses thereof
WO2001012806A3 (fr) 'odorant-binding' proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications
WO1998057983A3 (fr) Proteine de mammifere de type facteur de croissance nerveuse
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
WO2003027251A3 (fr) Nouvelles molecules de la famille des proteines du domaine de pyrine et leur utilisation
WO2001007479A3 (fr) Matieres vivantes et methodes utiles pour le diagnostic ou le traitement de maladies
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
EP1210110A4 (fr) Proteines de liaison a la proteine prion, et leurs utilisations
IL134436A0 (en) Neisseria lactoferrin binding protein
EP0885959A3 (fr) Protéine Wnt-5b humaine
EP1263940A4 (fr) Polynucleotides et polypeptides de la proteine tyrosine phosphatase, et anticorps
CA2140091A1 (fr) Peptides et antiserums pour la detection de la cyclooxygenase-1 et de la cyclooxygenase-2 humaines
WO2001002429A3 (fr) Angiopoietine 6 et ses utilisations
WO2003033675A3 (fr) Identification de partenaires de liaison pour des proteines specifiques
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
WO1999038885A3 (fr) Nouveaux composes
WO2002036633A3 (fr) Nouvelles proteines humaines 7tm et polynucleotides codant pour ces proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2381712

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000958685

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 70130/00

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000958685

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000958685

Country of ref document: EP